Cempra Inc. Presents Full Data Set of Phase 2 Clinical Trial of CEM-101 (Solithromycin) in Community-Acquired Bacterial Pneumonia Patients at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)